LIVINGSTONE HEALTH HOLDINGS LIMITED

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2023-04 to 2024-03🗂️ Report periods on file: 2023-04 to 2024-03, 2022-04 to 2023-03, 2021-04 to 2022-03

In its 2023-04 to 2024-03 reporting, LIVINGSTONE HEALTH HOLDINGS LIMITED disclosed greenhouse gas emissions of 61.59 tCO2e/year (Scope 2). By scope: Scope 2: 61.59 tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
61.59 tCO2e/year (Scope 2)
2023-04 to 2024-03
⚙️
Energy Use
147.77 MWh/year
2023-04 to 2024-03

📊 Emissions by Scope (2023-04 to 2024-03)

ScopeWhat it coversReported value
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.61.59 tCO2e/year

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

📈 Emissions by Report Period

Report periodHeadline emissions figure reported
2023-04 to 2024-0361.59 tCO2e/year (Scope 2)
2022-04 to 2023-0344.75 tCO2e/year

Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

🔜 Short-term

  • Constantly deliver high-quality and efficient healthcare services to our patients.
  • Expand Phoenix Medical Group’s physical footprint.

📅 Medium-term

  • Constantly deliver high-quality and efficient healthcare services to our patients.
  • Continue to expand Phoenix Medical Group’s physical footprint.

🌱 ESG Focus Areas

Anti-CorruptionCustomer Health and SafetyDiversity and Equal OpportunityEconomic PerformanceEmissionsWasteEmploymentEnergyOccupational Health and SafetyTraining and EducationCustomer Privacy

⚠️ Challenges & Risks +

  • Revenue declined by 22.9% due to doctor attrition in the first half of the financial year.
  • Higher fixed operating costs and depreciation for new clinics.
  • Certain accounting provisions and non-recurring expenses, including impairment loss on goodwill, impairment loss on financial assets and plant and equipment written-off.
  • Rising costs of medical supplies and pharmaceuticals, as well as increased operational expenses due to inflation.

📋 Report Information

Reporting Period: 2023-04 to 2024-03
Frameworks: GRI Universal Standards 2021, TCFD
Assurance: CLA Global TS Risk Advisory Pte. Ltd. (internal review)